Literature DB >> 19925845

Parkinson's disease: Exit toxins, enter genetics.

Marie Westerlund1, Barry Hoffer, Lars Olson.   

Abstract

Parkinson's disease was long considered a non-hereditary disorder. Despite extensive research trying to find environmental risk factors for the disease, genetic variants now stand out as the major causative factor. Since a number of genes have been implicated in the pathogenesis it seems likely that several molecular pathways and downstream effectors can affect the trophic support and/or the survival of dopamine neurons, subsequently leading to Parkinson's disease. The present review describes how toxin-based animal models have been valuable tools in trying to find the underlying mechanisms of disease, and how identification of disease-linked genes in humans has led to the development of new transgenic rodent models. The review also describes the current status of the most common genetic susceptibility factors for Parkinson's disease identified up to today. Copyright 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19925845      PMCID: PMC4155944          DOI: 10.1016/j.pneurobio.2009.11.001

Source DB:  PubMed          Journal:  Prog Neurobiol        ISSN: 0301-0082            Impact factor:   11.685


  139 in total

1.  The ubiquitin carboxy-terminal hydrolase-L1 gene S18Y polymorphism does not confer protection against idiopathic Parkinson's disease.

Authors:  G D Mellick; P A Silburn
Journal:  Neurosci Lett       Date:  2000-10-27       Impact factor: 3.046

2.  Type and frequency of mutations in the LRRK2 gene in familial and sporadic Parkinson's disease*.

Authors:  Daniela Berg; Katherine J Schweitzer; Petra Leitner; Alexander Zimprich; Peter Lichtner; Petra Belcredi; Theresa Brüssel; Claudia Schulte; Sylvia Maass; Thomas Nägele; Zbigniew K Wszolek; Thomas Gasser
Journal:  Brain       Date:  2005-12       Impact factor: 13.501

3.  Escaping Parkinson's disease: a neurologically healthy octogenarian with the LRRK2 G2019S mutation.

Authors:  Denise M Kay; Patricia Kramer; Don Higgins; Cyrus P Zabetian; Haydeh Payami
Journal:  Mov Disord       Date:  2005-08       Impact factor: 10.338

4.  Progressive parkinsonism in mice with respiratory-chain-deficient dopamine neurons.

Authors:  Mats I Ekstrand; Mügen Terzioglu; Dagmar Galter; Shunwei Zhu; Christoph Hofstetter; Eva Lindqvist; Sebastian Thams; Anita Bergstrand; Fredrik Sterky Hansson; Aleksandra Trifunovic; Barry Hoffer; Staffan Cullheim; Abdul H Mohammed; Lars Olson; Nils-Göran Larsson
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-16       Impact factor: 11.205

5.  The Ala53Thr mutation in the alpha-synuclein gene in a Korean family with Parkinson disease.

Authors:  C-S Ki; E F Stavrou; N Davanos; W Y Lee; E J Chung; J-Y Kim; A Athanassiadou
Journal:  Clin Genet       Date:  2007-05       Impact factor: 4.438

6.  Is the common LRRK2 G2019S mutation related to dyskinesias in North African Parkinson disease?

Authors:  S Lesage; S Belarbi; A Troiano; C Condroyer; N Hecham; P Pollak; E Lohman; T Benhassine; F Ysmail-Dahlouk; A Dürr; M Tazir; A Brice
Journal:  Neurology       Date:  2008-11-04       Impact factor: 9.910

7.  The relationship between radioactivity and norepinephrine concentrations in the brains and hearts of mice following administration of labeled methyldopa or 6-hydroxydopamine.

Authors:  C C Porter; J A Totaro; A Burcin
Journal:  J Pharmacol Exp Ther       Date:  1965-10       Impact factor: 4.030

8.  MPTP, MPP+ and mitochondrial function.

Authors:  W J Nicklas; S K Youngster; M V Kindt; R E Heikkila
Journal:  Life Sci       Date:  1987-02-23       Impact factor: 5.037

9.  S18Y polymorphism in the UCH-L1 gene and Parkinson's disease: evidence for an age-dependent relationship.

Authors:  Alexis Elbaz; Clotilde Levecque; Jacqueline Clavel; Jean-Sébastien Vidal; Florence Richard; Jean-René Corrèze; Bernard Delemotte; Philippe Amouyel; Annick Alpérovitch; Marie-Christine Chartier-Harlin; Christophe Tzourio
Journal:  Mov Disord       Date:  2003-02       Impact factor: 10.338

10.  Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease.

Authors:  K Uéda; H Fukushima; E Masliah; Y Xia; A Iwai; M Yoshimoto; D A Otero; J Kondo; Y Ihara; T Saitoh
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-01       Impact factor: 11.205

View more
  20 in total

Review 1.  Targeting TNF-α to elucidate and ameliorate neuroinflammation in neurodegenerative diseases.

Authors:  Kathryn A Frankola; Nigel H Greig; Weiming Luo; David Tweedie
Journal:  CNS Neurol Disord Drug Targets       Date:  2011-05       Impact factor: 4.388

2.  Blood-CNS barrier, neurodegeneration and neuroprotection: recent therapeutic advancements and nano-drug delivery.

Authors:  Hari S Sharma
Journal:  J Neural Transm (Vienna)       Date:  2011-01       Impact factor: 3.575

3.  Variable PARK2 Mutations Cause Early-Onset Parkinson's Disease in a Small Restricted Population.

Authors:  Shay Ben-Shachar; Zaid Afawi; Rafik Masalha; Samih Badarny; Tova Neiman; Dina Pavzner; Anat Bar-Shira; Avi Orr-Urtreger
Journal:  J Mol Neurosci       Date:  2017-09-15       Impact factor: 3.444

Review 4.  α-Synuclein, leucine-rich repeat kinase-2, and manganese in the pathogenesis of Parkinson disease.

Authors:  Jason P Covy; Benoit I Giasson
Journal:  Neurotoxicology       Date:  2011-01-14       Impact factor: 4.294

5.  Impaired nigrostriatal function precedes behavioral deficits in a genetic mitochondrial model of Parkinson's disease.

Authors:  Cameron H Good; Alexander F Hoffman; Barry J Hoffer; Vladimir I Chefer; Toni S Shippenberg; Cristina M Bäckman; Nils-Göran Larsson; Lars Olson; Sandra Gellhaar; Dagmar Galter; Carl R Lupica
Journal:  FASEB J       Date:  2011-01-13       Impact factor: 5.191

6.  Microarray expression profiling in 6-hydroxydopamine-induced dopaminergic neuronal cell death.

Authors:  Bokyung Park; Chang-Ki Oh; Won-Seok Choi; In Kwon Chung; Moussa B H Youdim; Young J Oh
Journal:  J Neural Transm (Vienna)       Date:  2011-09-09       Impact factor: 3.575

7.  Neuroprotective changes of striatal degeneration-related gene expression by acupuncture in an MPTP mouse model of Parkinsonism: microarray analysis.

Authors:  Yeong-Gon Choi; Sujung Yeo; Yeon-Mi Hong; Sabina Lim
Journal:  Cell Mol Neurobiol       Date:  2010-11-25       Impact factor: 5.046

8.  Characterization of cellular protective effects of ATP13A2/PARK9 expression and alterations resulting from pathogenic mutants.

Authors:  Jason P Covy; Elisa A Waxman; Benoit I Giasson
Journal:  J Neurosci Res       Date:  2012-07-30       Impact factor: 4.164

9.  Heat shock protein 90 in neurodegenerative diseases.

Authors:  Wenjie Luo; Weilin Sun; Tony Taldone; Anna Rodina; Gabriela Chiosis
Journal:  Mol Neurodegener       Date:  2010-06-03       Impact factor: 14.195

10.  Unbiased screen reveals ubiquilin-1 and -2 highly associated with huntingtin inclusions.

Authors:  Nicola J Rutherford; Jada Lewis; Amy K Clippinger; Michael A Thomas; Jennifer Adamson; Pedro E Cruz; Ashley Cannon; Guilian Xu; Todd E Golde; Gerry Shaw; David R Borchelt; Benoit I Giasson
Journal:  Brain Res       Date:  2013-06-15       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.